| The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction GUSTO Angiographic Investigators New England Journal of Medicine 329 (22), 1615-1622, 1993 | 2141 | 1993 |
| Percutaneous repair or medical treatment for secondary mitral regurgitation JF Obadia, D Messika-Zeitoun, G Leurent, B Iung, G Bonnet, N Piriou, ... New England Journal of Medicine 379 (24), 2297-2306, 2018 | 1619 | 2018 |
| Registry of transcatheter aortic-valve implantation in high-risk patients M Gilard, H Eltchaninoff, B Iung, P Donzeau-Gouge, K Chevreul, J Fajadet, ... New England Journal of Medicine 366 (18), 1705-1715, 2012 | 1434 | 2012 |
| Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study ML Simoons, W Rutsch, A Vahanian, J Adgey, A Maseri, C Vassanelli, ... Lancet 349 (9063), 1429-1435, 1997 | 1270 | 1997 |
| Bedside monitoring to adjust antiplatelet therapy for coronary stenting JP Collet, T Cuisset, G Rangé, G Cayla, S Elhadad, C Pouillot, P Henry, ... New England Journal of Medicine 367 (22), 2100-2109, 2012 | 1058 | 2012 |
| Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten … MA Hlatky, DB Boothroyd, DM Bravata, E Boersma, J Booth, MM Brooks, ... The lancet 373 (9670), 1190-1197, 2009 | 956 | 2009 |
| Polymer-free drug-coated coronary stents in patients at high bleeding risk P Urban, IT Meredith, A Abizaid, SJ Pocock, D Carrié, C Naber, J Lipiecki, ... New England Journal of Medicine 373 (21), 2038-2047, 2015 | 837 | 2015 |
| Sirolimus-eluting versus uncoated stents in acute myocardial infarction C Spaulding, P Henry, E Teiger, K Beatt, E Bramucci, D Carrié, MS Slama, ... New England Journal of Medicine 355 (11), 1093-1104, 2006 | 822 | 2006 |
| Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry H Eltchaninoff, A Prat, M Gilard, A Leguerrier, D Blanchard, G Fournial, ... European heart journal 32 (2), 191-197, 2011 | 707 | 2011 |
| Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy … P Vranckx, M Valgimigli, P Jüni, C Hamm, PG Steg, D Heg, GA van Es, ... The Lancet 392 (10151), 940-949, 2018 | 690 | 2018 |
| A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II … PW Serruys, B Chevalier, D Dudek, A Cequier, D Carrié, A Iniguez, ... The Lancet 385 (9962), 43-54, 2015 | 671 | 2015 |
| Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year … PW Serruys, B Chevalier, Y Sotomi, A Cequier, D Carrié, JJ Piek, ... The Lancet 388 (10059), 2479-2491, 2016 | 590 | 2016 |
| Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the … DJFM Thuijs, AP Kappetein, PW Serruys, FW Mohr, MC Morice, MJ Mack, ... The Lancet 394 (10206), 1325-1334, 2019 | 533 | 2019 |
| A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent: the SPIRIT II trial. PW Serruys, P Ruygrok, J Neuzner, JJ Piek, A Seth, JJ Schofer, ... EuroIntervention: journal of EuroPCR in collaboration with the Working Group …, 2006 | 443 | 2006 |
| Consensus document on the radial approach in percutaneous cardiovascular interventions: position paper by the European Association of Percutaneous Cardiovascular Interventions … M Hamon, C Pristipino, C Di Mario, J Nolan, J Ludwig, M Tubaro, ... EuroIntervention 8 (11), 1242-51, 2013 | 432 | 2013 |
| 6-versus 24-month dual antiplatelet therapy after implantation of drug-eluting stents in patients nonresistant to aspirin: the randomized, multicenter ITALIC trial M Gilard, P Barragan, AAL Noryani, HA Noor, T Majwal, T Hovasse, ... Journal of the American College of Cardiology 65 (8), 777-786, 2015 | 419 | 2015 |
| Cardiotoxicity of high-dose continuous infusion fluorouracil: a prospective clinical study. M De Forni, MC Malet-Martino, P Jaillais, RE Shubinski, JM Bachaud, ... Journal of Clinical Oncology 10 (11), 1795-1801, 1992 | 393 | 1992 |
| Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial O Varenne, S Cook, G Sideris, S Kedev, T Cuisset, D Carrié, T Hovasse, ... The Lancet 391 (10115), 41-50, 2018 | 379 | 2018 |
| Platelet function monitoring to adjust antiplatelet therapy in elderly patients stented for an acute coronary syndrome (ANTARCTIC): an open-label, blinded-endpoint, randomised … G Cayla, T Cuisset, J Silvain, F Leclercq, S Manzo-Silberman, ... The Lancet 388 (10055), 2015-2022, 2016 | 366 | 2016 |
| Early increase of von Willebrand factor predicts adverse outcome in unstable coronary artery disease: beneficial effects of enoxaparin G Montalescot, F Philippe, A Ankri, E Vicaut, E Bearez, JE Poulard, ... Circulation 98 (4), 294-299, 1998 | 321 | 1998 |
